CONTACT US

Ranbaxy Laboratories Limited Corporate Office Plot 90, Sector 32, Gurgaon -122001 (Haryana), INDIA Ph: 91- 124- 4135000 Fax: 91-124-4135001

Registered Office A-41, Industrial Area Phase VIII-A, Sahibzada Ajit Singh Nagar, Mohali - 160 071 (Punjab), INDIA

Other Contacts

Corporate Affairs & Global Corporate Communications Research & Development Center Worldwide Operations

Media Queries Global API Ranbaxy Community Healthcare Society

Investor Relations Global Consumer Healthcare Ranbaxy Science Foundation

CORPORATE AFFAIRS & GLOBAL CORPORATE COMMUNICATIONS

Mr. Ramesh Adige President, Corporate Affairs & Global Corporate Communications Ranbaxy Laboratories Limited Corporate Office, Plot 90, Sector 32, Gurgaon -122001 (Haryana), INDIA Ph: +91-124-4135000

Email: ramesh.adige@ranbaxy.com

MEDIA QUERIES
Mr. Raghunandan Kochar Director, Corporate Communications Ph: +91-124-4135141, 4135000 Email: raghu.kochar@ranbaxy.com

Mr. Krishnan Ramalingam General Manager, Corporate Communications Ph: +91-124-4135143, 4135000 Email: krishnan.ramalingam@ranbaxy.com

INVESTOR RELATIONS Registration of Complaints by Investors

Mr. S. K. Patawari Company Secretary Ranbaxy Laboratories Ltd. Plot No. 90, Sector 32 Gurgaon - 122001 (Haryana), India Ph: +91-124-4135000 Fax: +91-124-4106490 Email: secretarial@ranbaxy.com

Secretarial Services

Mr. Navneet Raghuvanshi Deputy Company Secretary Email: navneet.raghuvanshi@ranbaxy.com

RESEARCH & DEVELOPMENT CENTER

Plot No. 20, Sector - 18, Udyog Vihar Industrial Area Gurgaon, Haryana-122001, INDIA Ph: 91- 124 2342001-10 Email: udbhav.ganjoo@ranbaxy.com

GLOBAL API
Mr. Govind K Jaju Senior Vice President - Global Material Sourcing and API Business

Ranbaxy Laboratories Limited Plot No. 90, Sector 32 Gurgaon - 122 001, India Email: api@ranbaxy.com

GLOBAL CONSUMER HEALTHCARE

Mr. Brijesh Kapil Vice President Ranbaxy Global Consumer Healthcare Corporate Office, Plot 90, Sector 32, Gurgaon -122001 (Haryana), INDIA Ph: +91-124-4135000 Email: brijesh.kapil@ranbaxy.com

RANBAXY COMMUNITY HEALTHCARE SOCIETY

Dr. R.S.Bakshi Chief Medical Officer-RCHS Corporate Office, Plot 90, Sector 32, Gurgaon -122001 ( Haryana), INDIA Ph: +91- 124- 4135000 Email: ranbir.bakshi@ranbaxy.com

RANBAXY SCIENCE FOUNDATION

Mr. Dr. Rajinder K Jalali Vice President Ranbaxy Research Laboratories Limited, Plot No. 77B, Sector - 18, IFFCO Road, Gurgaon -122001 (Haryana), INDIA Ph: +91-124-5194207 Email: rajinder.jalali@ranbaxy.com

About Us
Company Profile
Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 46 countries, world-class manufacturing facilities in 7 countries and serves customers in over 125 countries. In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 20 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing.

Mission

Ranbaxy's mission is Enriching lives globally, with quality and affordable pharmaceuticals..

Financials
Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2010, the Company recorded Global Sales of US $ 1868 Mn. The Company has a balanced mix of revenues from emerging and developed markets that contribute 50% and 44% respectively. In 2009, North America, the Company's largest market contributed sales of US $ 660 Mn, followed by Europe garnering US $ 272 Mn and Asia clocking sales of US $ 468 Mn.

Strategy
Ranbaxy is focused on increasing the momentum in the generics business in its key markets through organic and inorganic growth routes. Growth is well spread across geographies with focus on developed and emerging markets. It is the Companys constant endeavour to provide a wide basket of generic and innovator products, leveraging the unique Hybrid Business Model with Daiichi Sankyo. The Company will also increasingly focus in high growth potential segments like Vaccines and Biogenerics. These new areas will add significant depth to the existing product pipeline.

R&D
Ranbaxy views its R&D capabilities as a vital component of its business strategy that will provide a sustainable, long-term competitive advantage. The Company has a pool of over 1,200 R&D personnel engaged in path-breaking research. Ranbaxy is among the few Indian pharmaceutical companies in India to have started its research program in the late 70's, in support of its global ambitions. A first-of-its-kind world class R&D centre was commissioned in 1994. Today, the Company has multi-disciplinary R&D centers at Gurgaon, in India, with dedicated facilities for generics research and innovative research. The R&D environment reflects its commitment to be a leader in the generics space offering value added formulations and development of NDA/ANDAs, based on its Novel Drug Delivery System (NDDS) research capability. Ranbaxys first significant international success using the NDDS techn ology platform came in September 1999, when the Company out-licensed its first once-a-day formulation to a multinational company. In July 2010, Ranbaxys New Drug Discovery Research (NDDR) was transferred to Daiichi Sankyo India Pharma Private Limited as part of the strategy to strengthen the global Research and Development structure of the Daiichi Sankyo Group. While NDDR will now become an integral part of Daiichi Sankyo Life Science Research Center in India, based in Gurgaon, Ranbaxy will continue to independently develop and later commercialise the anti-malarial new drug, Arterolane + PQP, which is currently in Phase III trials. Ranbaxy will also explore the further development of late stage programs developed by NDDR in the last few years, including the development programs in the GSK collaboration. Within Ranbaxy, R&D of Generics will now get a sharper focus, as the Company is increasingly working on more complex and specialist areas.

People
The Companys business philosophy based on delivering value to its stakeholders constantly in spires its people to innovate, achieve excellence and set new global benchmarks. Driven by the passion of its around 14,000 strong multicultural workforce comprisi ng of over 50 nationalities, Ranbaxy continues to aggressively pursue its mission of 'Enriching lives globally, with quality and affordable pharmaceuticals'.

Board of Directors
At the helm of the entire operations is the experience and able direction of the people who make it all happen. Ranbaxy acknowledges their inspiring stewardship and indefatigable work.

Dr. Tsutomu Une Chairman Non Executive & Non Independent Director Mr. Arun Sawhney CEO & Managing Director

Mr. Takashi Shoda Non Executive & Non Independent Director Dr. Anthony H. Wild Independent Director Mr. Rajesh V. Shah Independent Director Mr. Akihiro Watanabe Independent Director Mr. Percy K. Shroff Independent Director

Executive Team
The Executive Committee is an apex body at Ranbaxy, that oversees Company's global functioning. The group deliberates on important Company issues steering it in the right direction. The Committee ensures that all decisions are taken in the best interest of the organisation. This forum brings in different perspectives on a subject. Issues are discussed, analysed and concluded through exchange of ideas, reflecting the Company's philosophy of participative management. It also facilitates the Company's compliance with the best standards of Corporate Governance. Mr. Arun Sawhney CEO & Managing Director Dr. Sudershan K. Arora President Research & Development Mr. Rajiv Gulati President Global Pharmaceuticals Business Mr. Dale Adkisson Head - Global Quality Mr. Hiroyuki Okuzawa Head Global Synergy Project

Contact
Mr. Sanjeev Dani Senior Vice President & Regional Director Asia, CIS & Africa Ranbaxy Laboratories Limited Corporate Office, Plot 90, Sector 32, Gurgaon -122001 (Haryana), INDIA Ph: +91- 124- 4135000 Email: mukta.v@ranbaxy.com

Products
Using the finest R&D and Manufacturing facilities, Ranbaxy Laboratories Limited manufacture and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. The Company remains focused on ascending the value chain in the marketing of pharmaceutical substances and is determined to bring in increased revenues from dosage forms sales. Ranbaxy's diverse product basket of over 5,000 SKUs available in over 125 countries worldwide, encompasses a wide therapeutic mix covering a majority of the chronic and acute segments. Healthcare trends project that the chronic treatment segments will outpace the acute treatment segments, primarily driven by a growing aging population and dominance of lifestyle diseases. Our robust performance in Cardiovasculars, Central Nervous System, Respiratory, Dermatology, Orthopedics, Nutritionals and Urology segments, clearly indicates that the Company has strengthened its presence in the fast-growing chronic and lifestyle disease segments.

Top 10 Molecules (2010)

Valacyclovir Simvastatin Donepezil Atorvastatin & Combinations Co-amoxyclav & Combinations Ciprofloxacin & Combinations Ketorolac Tromethamine Imipenem+Cilastatin Ginseng+Vitamins Loratadine & Combinations

Sister Concern Companies.

There is no any sister concern companies.

Future Prospects
The Indian pharmaceutical industry is also getting increasingly U.S. FDA compliant to harness the growth opportunities in areas of contract manufacturing and research. Indian companies such as Ranbaxy are increasingly focusing on tapping the U.S. generic market. There are many multinational pharmaceutical companies who are looking forward to India as an attractive destination for Research & Development, contract manufacturing, clinical trials conduct and generic drug research. In 2005, the market value of Indian Pharmaceutical Industry was US$ 45billion in 2005, and the generic sector is expected to grow to US$ 100 billion in the next few years.

Careers
At Ranbaxy, we believe that human capital forms a part of our organization's portfolio of privileged assets. Ranbaxy is a company offering diversity within a fast-paced entrepreneurial environment. Whether in the manufacturing or administrative areas of RPI, we offer employees ample opportunities to grow, take control, and be decision-makers. We have the advantages of a small company, where our employees can gain exposure to multiple areas of expertise and be an influence in the company; along with the advantages of being part of a global business with many successful years of experience. We seek competent and capable candidates who are highly motivated and flexible. Ranbaxy Inc. is an equal opportunity employer. . Beyond an exciting and diverse working environment, RPI offers its employees a competitive salary and benefits plan including: Comprehensive Medical, Dental and Vision Care programs A 401(k) plan

Company paid life insurance Company paid short and long term disability Paid vacations and PTO days Bonus program Please note that employee benefits may change at the company's discretion.

Departmental Descriptions
Ranbaxy is a dynamic, growing organization, and is always open to receiving resumes from qualified individuals. Below, we provide descriptions of the departments within our company; please feel free to read through these and submit a resume if you are interested in joining our team. Please search our current job openings by clicking here. Should your background match a current opening, you will be contacted. Your resume will remain on file for a period of one-year. Accounting and Finance Human Resources Information Technology Sales and Marketing Business Development Creative Services Drug Safety and Pharmacovigilance Regulatory Accounting and Finance Potential employees must be well-skilled in the accounting and finance arenas. Candidates possessing SAP R/3 background can expect to expand their knowledge of the product and provide valuable guidance to the company. Typically, Finance employees will be exposed to all facets of the accounting and finance functions as well as heavy interaction with multiple levels within the organization. Human Resources Candidates seeking a career in Human Resources should be well organized, motivated, able to adapt quickly to change, possess a good working knowledge of compensation, benefits, employment/recruitment and employee relations. In addition, candidates must demonstrate a high degree of written and verbal communication skills. Information Technology SAP R/3 is the latest in ERP software. Ranbaxy runs SAP R/3 ERP software. Qualified candidates will have at least two years IT experience, complete working knowledge of the Windows Operating System, networking and other software packages including SAP R/3. Sales and Marketing The Sales divisions including Brand, Generic, and OTC Sales call on targeted hospitals, wholesalers, distributors and large retail chains to sell a variety of Ranbaxy products. Candidates seeking a marketing career should possess outstanding communications skills and have at least two years of previous marketing experience coupled with a bachelor's degree in business or marketing. Business Development Business Development seeks and evaluates business and product opportunities for Ranbaxy. Prospective candidates should have a maximum of a bachelor's degree, an advanced degree preferably coupled with a scientific background and strong financial and quantitative skills. Creative Services

The Creative Services Department serves as an in-house resource for creative solutions responsible for the creation and design of packaging, advertising and collateral material. Drug Safety and Pharmacovigilance Drug Safety and Pharmacovigilance focuses on the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Candidates seeking a position in Drug Safety should have 1-2 years Drug Safety experience in the pharmaceutical industry. Medical candidates seeking a position in Drug Safety should have a relevant college degree in a health related field; holders of Pharmacist (RPh), MS, PharmD and MD degrees are highly preferred. Regulatory The Regulatory team plays critical roles throughout the product lifecycle, from concept through product commercialization. The team provides strategic, tactical and operational direction and support for working within regulations to expedite the development and delivery of safe and effective products for the healthcare system. Continuous changes in the regulatory environment, as well as new science shape the dynamic and expanding scope of the Regulatory team. Regulatory employees must continually grow their knowledge and skills to be effective and to advance in their careers. Most individuals enter the Regulatory profession with prior relevant professional experience and many have previous experience in scientific and clinical research, clinical laboratory work, clinical professions such as medicine or pharmacy, quality and manufacturing.

Qualification required for all the profiles.

The candidates should be B. Pharmacy or M.Sc. in Biochemistry, Pharmaceutical Chemistry/Organic Chemistry/Microbiology/ Biotechnology.